Clinical Predictors of Cardiovascular Implantable Electronic Device‐Related Infective Endocarditis

Background: Cardiovascular implantable electronic device (CIED)‐related infective endocarditis (CIED‐IE) is a serious complication of cardiac device infection and is associated with increased mortality. At present, there exist no criteria to predict CIED‐IE in patients who present with CIED infection.

[1]  L. Baddour,et al.  Temporal trends in permanent pacemaker implantation: a population-based study. , 2008, American heart journal.

[2]  R. Darouiche,et al.  Treatment of infections associated with surgical implants. , 2004, The New England journal of medicine.

[3]  Z. Goldberger,et al.  Implantable cardioverter-defibrillators: expanding indications and technologies. , 2006, JAMA.

[4]  M. Brickner,et al.  Transesophageal Echocardiography: Clinical Indications and Applications , 2003, Circulation.

[5]  Vance G. Fowler,et al.  Staphylococcus aureus Bacteremia in Patients With Permanent Pacemakers or Implantable Cardioverter-Defibrillators , 2001, Circulation.

[6]  Lisa Mielniczuk,et al.  Reasons for escalating pacemaker implants. , 2006, The American journal of cardiology.

[7]  David Longworth,et al.  Diagnosis and Management of Infections Involving Implantable Electrophysiologic Cardiac Devices , 2000, Annals of Internal Medicine.

[8]  H Le Breton,et al.  Pacemaker lead infection: echocardiographic features, management, and outcome , 1999, Heart.

[9]  D Lacroix,et al.  Local symptoms at the site of pacemaker implantation indicate latent systemic infection , 2004, Heart.

[10]  D. Lacroix,et al.  Single Center Experience with Femoral Extraction of Permanent Endocardial Pacing Leads , 1999, Pacing and clinical electrophysiology : PACE.

[11]  David L Hayes,et al.  Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. , 2008, Mayo Clinic proceedings.

[12]  G. Trevi,et al.  Accuracy of Swabs, Tissue Specimens, and Lead Samples in Diagnosis of Cardiac Rhythm Management Device Infections , 2009, Pacing and clinical electrophysiology : PACE.

[13]  V. Fowler,et al.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  M. Sohail.  Concerning diagnosis and management of pacemaker endocarditis. , 2007, Pacing and clinical electrophysiology : PACE.

[15]  I. Lossos,et al.  Pacemaker endocarditis. Report of 44 cases and review of the literature. , 1994, Medicine.

[16]  Jacques Victor,et al.  Risk Factors Related to Infections of Implanted Pacemakers and Cardioverter-Defibrillators: Results of a Large Prospective Study , 2007, Circulation.

[17]  R. Darouiche,et al.  Nonstaphylococcal Infections of Cardiac Implantable Electronic Devices , 2010, Circulation.

[18]  A. Greenspon,et al.  Lead‐Associated Endocarditis: The Important Role of Methicillin‐Resistant Staphylococcus aureus , 2008, Pacing and clinical electrophysiology : PACE.

[19]  P. Massoure,et al.  Pacemaker Endocarditis: Clinical Features and Management of 60 Consecutive Cases , 2007, Pacing and clinical electrophysiology : PACE.

[20]  F. Raffi,et al.  Sustained bacteremia in 26 patients with a permanent endocardial pacemaker: assessment of wire removal. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  R. Courcol,et al.  Detailed bacteriologic tests to identify the origin of transvenous pacing system infections indicate a high prevalence of multiple organisms. , 2005, American heart journal.

[22]  A. Dello Russo,et al.  Residual fibrous tissue floating in the right atrium after percutaneous pacemaker lead extraction: an unusual complication early detected by intracardiac echocardiography. , 2008, International journal of cardiology.

[23]  H Lelièvre,et al.  Role of the preaxillary flora in pacemaker infections: a prospective study. , 1998, Circulation.

[24]  Walter R Wilson,et al.  Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. , 2010, Circulation.

[25]  P. Heidenreich,et al.  Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. , 2004, American heart journal.

[26]  G. Bluhm.  Pacemaker infections. A clinical study with special reference to prophylactic use of some isoxazolyl penicillins. , 2009, Acta medica Scandinavica. Supplementum.

[27]  A. Pavie,et al.  Pacemaker infective endocarditis. , 1998, The American journal of cardiology.

[28]  W. Saliba,et al.  Images in cardiovascular medicine. Fate of intracardiac lead vegetations after percutaneous lead extraction. , 2002, Circulation.

[29]  D. Durack,et al.  New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. , 1994, The American journal of medicine.

[30]  David L Hayes,et al.  Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. , 2007, Journal of the American College of Cardiology.

[31]  I Vilacosta,et al.  Impact of Left Ventricular Structure on the Incidence of Hypertension: The Framingham Heart Study , 1994 .